rivastigmine

Poland

Drugs containing this active substance

  • ATMINA

    Atmina is used in adult patients with mild to moderately severe Alzheimer's-type dementia to alleviate the symptoms of this disease.

    Form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 4.6 mg/24 h

    ATC: N06DA03

    Manufacturer: Luye Pharma AG

  • ATMINA

    The medicine is intended for adult patients with Alzheimer's-type dementia of mild to moderately severe severity.

    Form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 9.5 mg/24 h

    ATC: N06DA03

    Manufacturer: Luye Pharma AG

  • EVERTAS

    The medicine is used in adult patients with mild to moderately severe Alzheimer's-type dementia, which causes impairments in memory, intellectual abilities, and behavior.

    Form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 9.5 mg/24 h

    ATC: N06DA03

    Manufacturer: Zentiva, joint-stock company

  • EVERTAS

    The medicine is used in adult patients with mild to moderately severe Alzheimer's-type dementia, which causes impairments in memory, intellectual abilities, and behavior.

    Form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 19.2 mg

    ATC: N06DA03

    Manufacturer: Luye Pharma AG Zentiva SA

  • RIVALDO

    The medicine is used in adult patients for the treatment of mild to moderately severe Alzheimer's-type dementia and in the treatment of dementia in people with Parkinson's disease.

    Form: capsules, hard

    Active substance Dosage
    rivastigmine 1.5 mg

    ATC: N06DA03

    Manufacturer: Adamed Pharma S.A.

  • RIVALDO

    It is used in adult patients to relieve the symptoms of Alzheimer's disease (mild to moderate dementia) and dementia associated with Parkinson's disease.

    Form: capsules, hard

    Active substance Dosage
    rivastigmine 3 mg

    ATC: N06DA03

    Manufacturer: Adamed Pharma S.A.

  • RIVALDO

    The medicine is used in adult patients to relieve the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Form: capsules, hard

    Active substance Dosage
    rivastigmine 4.5 mg

    ATC: N06DA03

    Manufacturer: Adamed Pharma S.A.

  • RIVALDO

    The medicine is used in adult patients to relieve the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Form: capsules, hard

    Active substance Dosage
    rivastigmine 6 mg

    ATC: N06DA03

    Manufacturer: Adamed Pharma S.A.

  • RIVASTIGMINE MYLAN

    The medicine is intended for adult patients with mild to moderately severe Alzheimer's-type dementia, which causes problems with memory, behavior, and intellectual abilities.

    Form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 6.9 mg

    ATC: N06DA03

    Manufacturer: Luye Pharma AG

  • RIVASTIGMINE MYLAN

    The medicine is used in adult patients with mild to moderately severe Alzheimer's-type dementia, which causes impairments in memory, intellectual abilities, and behavior.

    Form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 13.8 mg

    ATC: N06DA03

    Manufacturer: Luye Pharma AG